Real-time enrollment status for this uveal melanoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:38 AM UTC
| NCT Number | NCT06581406 |
| Recruiting Status | Recruiting |
| Condition | Uveal Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 280 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Replimune Inc. |
| Last Updated on CT.gov | April 2, 2026 (Apr 2, 2026) |
As of July 18, 2026: Clinical trial NCT06581406 is currently recruiting participants. This phase2 study for uveal melanoma is actively seeking new participants at 29 locations across the United States. The study is sponsored by Replimune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06581406 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06581406 was last updated Apr 2, 2026 (April 2, 2026). HelloStudys verifies this status automatically.